Company Analysis
Sign in

BioLineRx Ltd. (BLRX)

Nasdaq: BLRX · Pharmaceutical Preparations · filing with the SEC since 2010
Full chart Alerts Compare
Grade4.2
◀ Past 4.2● Present 4.3▶ Future 4.1
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 23, 2026Mar 31, 2025Mar 26, 2024Mar 22, 2023Mar 16, 2022Feb 23, 2021Mar 12, 2020Mar 28, 2019Mar 6, 2018Mar 23, 2017
Revenue1,18028,9404,80000·····
Cost of revenue2309,2633,69200·····
Gross profit95019,6771,10800·····
Research and development8,0939,14912,51917,62919,46618,17323,43819,80819,51011,177
Selling, general and administrative3,1446,3216,3105,0664,3083,9143,8164,4354,0373,984
Sales and marketing023,60525,2706,4621,0038408571,3621,6931,352
Operating income-10,287-20,408-49,694-29,157-24,777-22,927-28,111-25,605-25,240-16,513
Finance costs1,2809,1192,1692,1581,0061,6292,2774732122
Finance income1,4641,8712,0686945592367777191,169480
Income tax expense0000000···
Net income-2,026-9,221-60,614-24,951-27,054-30,021-25,446-22,962-24,352-15,841
Net income to non-controlling interests6,000·········
Earnings per share, basic0.00-0.01-0.06-0.03-0.04-0.12····
Earnings per share, diluted0.00-0.01-0.06-0.03-0.04-0.12····
Earnings per share, basic and diluted·····-0.12-0.17-0.21-0.27-0.28
Weighted average shares, basic2,465,272,6041,198,107,761963,365,525773,956,973662,933,695252,844,394146,407,055108,595,70289,970,71356,144,727
Weighted average shares, diluted2,465,272,6041,198,107,761963,365,525·······
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Gross profit revenue less the cost of what it soldifrs-full:GrossProfit
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
Sales and marketing the cost of finding and serving customersifrs-full:SalesAndMarketingExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton BLRX · research, not advice